Dosni Roha Indonesia Past Earnings Performance
Past criteria checks 0/6
Dosni Roha Indonesia's earnings have been declining at an average annual rate of -71.7%, while the Healthcare industry saw earnings growing at 3.7% annually. Revenues have been growing at an average rate of 28.5% per year.
Key information
-71.7%
Earnings growth rate
-62.8%
EPS growth rate
| Healthcare Industry Growth | 14.1% |
| Revenue growth rate | 28.5% |
| Return on equity | -29.2% |
| Net Margin | -33.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Dosni Roha Indonesia makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 940,815 | -315,869 | 261,423 | 0 |
| 30 Jun 24 | 1,269,454 | -245,215 | 302,598 | 0 |
| 31 Mar 24 | 1,494,602 | -193,297 | 327,709 | 0 |
| 31 Dec 23 | 1,724,458 | -138,620 | 355,436 | 0 |
| 30 Sep 23 | 1,862,542 | -135,756 | 380,618 | 0 |
| 30 Jun 23 | 2,276,599 | -142,289 | 377,228 | 0 |
| 31 Mar 23 | 2,563,654 | -147,396 | 367,195 | 0 |
| 31 Dec 22 | 2,958,368 | -116,617 | 363,680 | 0 |
| 30 Sep 22 | 3,102,453 | -66,144 | 348,321 | 0 |
| 30 Jun 22 | 4,961,307 | -6,831 | 553,302 | 0 |
| 31 Mar 22 | 4,285,871 | 29,784 | 468,551 | 0 |
| 31 Dec 21 | 3,497,365 | 29,030 | 381,308 | 0 |
| 30 Sep 21 | 2,656,965 | 29,248 | 290,570 | 0 |
| 30 Jun 21 | 19,913 | 156 | 6,219 | 0 |
| 31 Mar 21 | 16,570 | 33 | 4,672 | 0 |
| 31 Dec 20 | 14,697 | -1,634 | 4,367 | 0 |
| 30 Sep 20 | 13,739 | 386 | 3,857 | 0 |
| 30 Jun 20 | 16,267 | -697 | 3,412 | 0 |
| 31 Mar 20 | 16,876 | -996 | 3,392 | 0 |
| 31 Dec 19 | 15,703 | -996 | 3,308 | 0 |
| 30 Sep 19 | 14,245 | -1,574 | 3,273 | 0 |
| 30 Jun 19 | 14,888 | -690 | 2,985 | 0 |
| 31 Mar 19 | 16,203 | -444 | 2,710 | 0 |
| 31 Dec 18 | 17,663 | -468 | 2,689 | 0 |
| 30 Sep 18 | 18,540 | -1,416 | 460 | 0 |
| 30 Jun 18 | 18,147 | -1,065 | 506 | 0 |
| 31 Mar 18 | 16,023 | 19 | 977 | 0 |
| 31 Dec 17 | 15,874 | 383 | 1,433 | 0 |
| 30 Sep 17 | 15,483 | -7,554 | 5,346 | 0 |
| 30 Jun 17 | 12,480 | -8,686 | 5,428 | 0 |
| 31 Mar 17 | 13,231 | -11,019 | 5,409 | 0 |
| 31 Dec 16 | 12,170 | -12,607 | 5,345 | 0 |
| 30 Sep 16 | 13,597 | -7,015 | 4,741 | 0 |
| 30 Jun 16 | 17,989 | -8,381 | 4,914 | 0 |
| 31 Mar 16 | 19,788 | -9,785 | 5,200 | 0 |
| 31 Dec 15 | 21,729 | -8,401 | 5,325 | 0 |
| 30 Sep 15 | 21,569 | -7,204 | 4,350 | 0 |
| 30 Jun 15 | 18,044 | -6,072 | 4,539 | 0 |
| 31 Mar 15 | 15,680 | -6,056 | 5,498 | 0 |
| 31 Dec 14 | 14,282 | -9,019 | 6,077 | 0 |
| 30 Sep 14 | 12,788 | -10,054 | 6,693 | 0 |
| 30 Jun 14 | 12,288 | -10,761 | 7,457 | 0 |
| 31 Mar 14 | 12,747 | -10,651 | 7,270 | 0 |
| 31 Dec 13 | 13,924 | -7,738 | 7,125 | 0 |
Quality Earnings: ZBRA is currently unprofitable.
Growing Profit Margin: ZBRA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ZBRA is unprofitable, and losses have increased over the past 5 years at a rate of 71.7% per year.
Accelerating Growth: Unable to compare ZBRA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ZBRA is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (2.7%).
Return on Equity
High ROE: ZBRA has a negative Return on Equity (-29.17%), as it is currently unprofitable.